Table 1.
Patient characteristics at enrollment according to revascularization strategy
| Characteristic | CABG (n = 2,784) |
PCI (n = 2,594) |
CABG+PCI (n = 788) |
No Previous Revascularization (n = 16,410) |
p Value† |
|---|---|---|---|---|---|
| Age (years) | 68.3 ± 8.8 | 66.2 ± 9.4 | 67.2 ± 9.2 | 65.6 ± 9.9 | <0.001 |
| Age >70 years | 42.7% | 33.3% | 37.1% | 31.6% | <0.001 |
| Body mass index (kg/m2) | 28.7 ± 5.0 | 29.2 ± 8.1 | 30.0 ± 14.7 | 29.2 ± 6.7 | <0.001 |
| Men | 71.3% | 60.8% | 68.4% | 40.8% | <0.001 |
| United States residency | 82.1% | 78.5% | 90.9% | 73.7% | <0.001 |
| Race/ethnicity | <0.001 | ||||
| White | 74.8% | 70.2% | 78.0% | 39.0% | |
| Black | 8.8% | 9.5% | 8.0% | 15.1% | |
| Hispanic | 14.2% | 18.4% | 11.8% | 43.1% | |
| Asian | 0.9% | 0.8% | 1.5% | 0.6% | |
| Other/multiracial | 1.3% | 1.1% | 0.6% | 2.2% | |
| Myocardial infarction | 47.8% | 51.5% | 55.6% | 25.1% | <0.001 |
| Angina pectoris | 31.7% | 38.3% | 42.4% | 78.2% | <0.001 |
| Unstable angina (≥1 month before enrollment) | 18.8% | 22.5% | 31.5% | 7.5% | <0.001 |
| Stroke/transient ischemic attack | 9.3% | 8.0% | 11.0% | 6.6% | 0.023 |
| Left ventricular hypertrophy | 19.5% | 17.9% | 18.3% | 23.1% | <0.001 |
| Arrhythmia | 8.7% | 7.1% | 10.0% | 6.7% | 0.012 |
| Heart failure class I–III | 7.5% | 4.4% | 9.5% | 5.2% | <0.001 |
| Peripheral vascular disease | 15.9% | 11.0% | 15.6% | 11.3% | <0.001 |
| Cigarette smoking (any history) | 58.7% | 58.4% | 60.2% | 41.6% | <0.001 |
| Diabetes | 34.1% | 27.8% | 35.0% | 27.1% | <0.001 |
| Renal impairment | 3.6% | 1.9% | 3.6% | 1.5% | <0.001 |
| Dyslipidemia | 74.0% | 75.4% | 79.1% | 48.5% | 0.013 |
| Antiplatelet drug therapy | 82.7% | 85.9% | 83.5% | 46.4% | 0.004 |
| Lipid-lowering drug therapy | 60.8% | 61.5% | 66.1% | 27.3% | 0.025 |
Data are presented as mean ± SD or %.
*
Comparing CABG, PCI, and CABG+PCI subpopulations.